Neurotransmitter and Immunomodulatory Actions of VIP and PACAP: Lessons from Knockout Mice

被引:0
作者
Catalina Abad
Pawel Niewiadomski
Dawn Hsiao-Wei Loh
James A. Waschek
机构
[1] Unidad de Investigación,Hospital 12 de Octubre
[2] University of California at Los Angeles,Mental Retardation Research Center, Semel Institute for Neuroscience, Department of Psychiatry
[3] NRB 345,undefined
[4] UCLA,undefined
来源
International Journal of Peptide Research and Therapeutics | 2006年 / 12卷
关键词
behavior; circadian; immune; knockout; mouse; neuropeptide; PACAP; phenotype; VIP;
D O I
暂无
中图分类号
学科分类号
摘要
Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylyl Cyclase Activating Peptide (PACAP) are two closely related neuropeptides in the secretin family. They are widely expressed in the central and peripheral nervous systems, where they are classically thought to act as neurotransmitters or neuromodulators. They interact with high affinity receptors to regulate numerous behaviors as well as gastrointestinal, endocrine, cardiopulmonary, reproductive and immune functions. The recent generation of mice that specifically lack or overexpress VIP, PACAP or their receptors has yielded much new knowledge and enabled investigators to better understand the biological roles of these peptides and their impact on health. In this review, we attempt to summarize the major findings, but focus in greatest detail on the circadian and immune functions.
引用
收藏
页码:297 / 310
页数:13
相关论文
共 429 条
  • [1] Abad C.(2003)undefined Gastroenterology 124 961-971
  • [2] Martinez C.(2001)undefined J. Immunol. 167 3182-3189
  • [3] Juarranz M. G.(2002)undefined Neuroimmunomodulation 10 177-186
  • [4] Arranz A.(2001)undefined Brain Res. 916 172-191
  • [5] Leceta J.(1991)undefined J. Neurosci. 11 846-851
  • [6] Delgado M.(2005)undefined Lancet 365 63-78
  • [7] Gomariz R. P.(2005)undefined Reg. Peptides 130 147-4006
  • [8] Abad C.(2002)undefined Endocrinology 143 3994-483
  • [9] Martinez C.(2005)undefined Nat. Neurosci. 8 476-364
  • [10] Leceta J.(2004)undefined Neuroimmunomodulation 11 358-1303